MIRO
Closed
Miromatrix Medical Inc
3.39
0.00 (0.00%)
Last Update: 22 Dec 2023 17:30:00
Yesterday: 3.39
Day's Range: 3.39 - 3.39
Send
sign up or login to leave a comment!
When Written:
1.55
Miromatrix Medical Inc is a medical technology company that focuses on developing and commercializing bioengineered transplantable organs and tissues. The company was founded in 2009 and is headquartered in Eden Prairie, Minnesota.
Miromatrix's platform technology is based on a process called perfusion decellularization, which involves removing the cells from an organ or tissue while preserving the extracellular matrix (ECM). This ECM is then repopulated with the patient's own cells, creating a personalized transplantable organ or tissue that is less likely to be rejected by the recipient's immune system.
The company's current focus is on developing bioengineered livers, kidneys, and heart valves for transplantation. Miromatrix has received funding from various sources, including the National Institutes of Health, the Department of Defense, and private investors. The company has also formed partnerships with other organizations, including Mayo Clinic and United Therapeutics Corporation.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Miromatrix's platform technology is based on a process called perfusion decellularization, which involves removing the cells from an organ or tissue while preserving the extracellular matrix (ECM). This ECM is then repopulated with the patient's own cells, creating a personalized transplantable organ or tissue that is less likely to be rejected by the recipient's immune system.
The company's current focus is on developing bioengineered livers, kidneys, and heart valves for transplantation. Miromatrix has received funding from various sources, including the National Institutes of Health, the Department of Defense, and private investors. The company has also formed partnerships with other organizations, including Mayo Clinic and United Therapeutics Corporation.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!
When Written:
1.55
Miromatrix Medical Inc is a biotechnology company that specializes in developing and commercializing regenerative medicine products. The company was founded in 2009 and is headquartered in Eden Prairie, Minnesota. Miromatrix Medical's technology platform involves using decellularization and recellularization techniques to create functional, transplantable organs and tissues. The company's products are designed to address the shortage of donor organs and improve patient outcomes in transplantation. Miromatrix Medical has received funding from various sources, including the National Institutes of Health, the U.S. Department of Defense, and private investors. The company's flagship product is a bioengineered liver that has shown promising results in preclinical studies. Miromatrix Medical is committed to advancing the field of regenerative medicine and improving the lives of patients in need of organ transplants.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!